Bavarian Nordic monkeypox vaccine gets preliminary nod from EU drug regulator

Bavarian Nordic monkeypox vaccine gets preliminary nod from EU drug regulator

By, Admin 23 July 2022

Bavarians vaccine the only one to have won approval for the prevention of monkeypox disease in the United States and Canada, has in the EU so far only been approved to treat smallpox. Danish biotechnology company Bavarian Nordic said on Friday the European Union's drug regulator had recommended its Imvanex vaccine be approved to also include protection against monkeypox on its label. The European Medicines Agency (EMA) had "adopted a positive opinion recommending that the marketing authorisation for the company's smallpox vaccine, IMVANEX, is extended to include protecting people from monkeypox disease," Bavarian said. Bavarian's vaccine, the only one to have won approval for the prevention of monkeypox disease in the United States and Canada, has in the EU so far only been approved to treat smallpox. But the company has supplied the vaccine to several EU countries during the current monkeypox outbreak for what is known as "off-label" use. "The extension of the label will help to improve access to the vaccine throughout Europe and strengthen the future preparedness against monkeypox," Bavarian CEO Paul Chaplin said in a statement. The recommendation from the EMA will be referred to the European Commission for final approval shortly, the company said

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!